Page 1 of Clinical Trials for Drug dasatinib, 187 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
A Study of Dasatinib (BMS-354825) in Patients With Advanced 'Triple-negative' Breast Cancer
Last Updated: February 18, 2011
Condition(s): Breast Cancer; Metastasis
2
Completed
Study of Dasatinib (BMS-354825) in Patients With Advanced Estrogen/Progesterone Receptor-positive (ER+/PR+) or Her2/Neu-positive (Her2/Neu+)Breast Cancer
Last Updated: April 21, 2011
Condition(s): Breast Cancer; Metastasis
3
Completed
Study of BMS-354825 (Dasatinib) in Patients With Chronic Myeloid Leukemia Who Are Either Resistant or Intolerant to Imatinib
Last Updated: February 29, 2012
Condition(s): Chronic Myeloid Leukemia; Philadelphia-Positive Myeloid Leukemia
4
Completed
Study of Oral Dasatinib in Subjects With Myelodysplastic Syndrome (MDS) and Excess Marrow Blasts
Last Updated: May 3, 2012
Condition(s): Myelodysplastic Syndromes
5
Terminated
Dasatinib in Advanced Non-small Cell Lung Cancer (NSCL) With Ex Vivo and In Vivo Assessment of Tumor Target Modulation
Last Updated: August 5, 2011
Condition(s): Lung Cancer
6
Recruiting
Dasatinib With Fludarabine and Rituximab in Relapsed and Refractory Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
Last Updated: April 20, 2012
Condition(s): Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma
7
Completed
Pharmacokinetic Study Comparing the Drug Levels in the Blood of Healthy Subjects Administered With the Tablet Formulation to the Drug Levels in the Blood of Healthy Subjects Administered With the Liquid and Tablet-dispersed Formulations
Last Updated: April 11, 2012
Condition(s): Leukemia
8
Not yet recruiting
Multimodal Molecular Targeted Therapy to Treat Relapsed or Refractory High-risk Neuroblastoma
Last Updated: April 15, 2012
Condition(s): Neuroblastoma Recurrent
9
Withdrawn
Ph. I Dasatinib/Protracted Temozolomide in Recurrent Malignant Glioma
Last Updated: January 22, 2009
Condition(s): Glioblastoma Multiforme; Gliosarcoma; Anaplastic Astrocytoma; Anaplastic Oligodendroglioma; Glioma
10
Recruiting
Valproic Acid-Based 2-Agent Oral Regimens for Patients With Advanced Solid Tumor
Last Updated: May 22, 2012
Condition(s): Solid Tumors
11
Recruiting
A Study Using Two Oral Chemotherapy Agents for Chronic Lymphocytic Leukemia
Last Updated: October 13, 2009
Condition(s): Chronic Lymphocytic Leukemia; Leukemia
12
Recruiting
Dasatinib (Sprycel™) in Patients With Newly Diagnosed Core Binding Factor (CBF) Acute Myeloid Leukemia (AML)
Last Updated: October 13, 2011
Condition(s): Acute Myeloid Leukemia (AML)
13
Completed
A Study of Dasatinib to See How Liver Impaired and Healthy Subjects Process and React to the Study Drug
Last Updated: April 13, 2011
Condition(s): Liver Diseases
14
Active, not recruiting
Solid Tumors Using Ixabepilone and Dasatinib
Last Updated: November 4, 2011
Condition(s): Solid Tumor
15
Completed
Dasatinib (BMS-354825) in Subjects With Myeloid Blast Phase Chronic Myeloid Leukemia Resistant to or Intolerant of Imatinib Mesylate
Last Updated: August 3, 2010
Condition(s): Chronic Myeloid Leukemia; Blast Crisis
16
Recruiting
Dasatinib and Gemcitabine Hydrochloride or Gemcitabine Hydrochloride Alone in Treating Patients With Pancreatic Cancer Previously Treated With Surgery
Last Updated: March 23, 2011
Condition(s): Acinar Cell Carcinoma of Pancreas; Duct Cell Adenocarcinoma of the Pancreas; Pancreatic Carcinoma Recurrent; Stage IA Pancreatic Cancer; Stage IB Pancreatic Cancer; Stage IIA Pancreatic Cancer; Stage IIB Pancreatic Cancer; Pancreatic Carcinoma Stage III
17
Active, not recruiting
XAD - Xelox (Capecitabine + Oxaliplatin) + Bevacizumab + Dasatinib
Last Updated: December 6, 2011
Condition(s): Solid Tumor; Metastatic Colorectal Cancer
18
Terminated
A Phase I/Expansion Study of Dasatinib
Last Updated: June 25, 2010
Condition(s): Refractory Solid Tumors; Pancreatic Adenocarcinoma
19
Withdrawn
Study of Dasatinib in Imatinib Resistant or Intolerant Subjects With Chronic or Advanced Phase CML or Philadelphia Chromosome Positive ALL
Last Updated: April 13, 2011
Condition(s): Chronic Myeloid Leukemia; Acute Lymphoblastic Leukemia
20
Recruiting
Dasatinib in Combination With Bevacizumab to Treat Advanced Solid Tumors
Last Updated: May 1, 2012
Condition(s): Solid Tumors

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Drug+dasatinib

Page 1 of Clinical Trials for Drug dasatinib, 187 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About